Clinical Trials Directory

Trials / Unknown

UnknownNCT05159336

Transcranial Alternating Current Stimulation (tACS) for Auditory Hallucinations

Intervention Treatment of Auditory Hallucination by Transcranial Alternating Current Stimulation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Transcranial alternating current stimulation (tACS) can modulate and restore neural oscillations that are reduced in patients with psychiatric illnesses such as schizophrenia. Here, we performed a open-lable study of clinical trial in 30 schizophrenia patients with auditory hallucinations to show that tACS is effective for auditory hallucinations.

Detailed description

Each week, the patient rested quietly with her eyes open while receiving alpha-frequency tACS for 40 minutes. Stimulation was delivered at 10 Hz with 1 mA zero-to-peak amplitude in-phase to the location 1 and the location 2 acquired by the MEG technique with 5\*5 cm electrodes. A 5\* 7 cm return electrode was centered on Cz. In total, 20 weeks.

Conditions

Interventions

TypeNameDescription
DEVICEtACS for auditory hallucinations via single arma 20 weeks, weekly 40 minutes, 1mA, 10Hz-tACS protocol

Timeline

Start date
2021-11-16
Primary completion
2023-03-30
Completion
2023-05-28
First posted
2021-12-16
Last updated
2021-12-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05159336. Inclusion in this directory is not an endorsement.